Weekly Twitter Roundup

Posted by Dan Vorhaus on December 11, 2009

Each week there are a number of stories and developments that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here’s a recap of what I was Tweeting this week @genomicslawyer:

British scientists demand libel law reform http://bit.ly/5OWUat (via @NatureNews) Claim: Journals avoiding manuscripts due to legal fears
Regulations to Implement GINA Move One Step Closer to Finalization: http://bit.ly/4RaXwV
Bioinformatics and mythology. You still need to manage the data: http://bit.ly/7uEIUz
RT @PHGFoundation: Faster access to treatments and diagnostics for rare diseases? http://bit.ly/5kPTlI
RT @ilanafish Simple test shows whether cancer drug will work – but NHS does not use it – Times Online: http://bit.ly/7sClmS
Israel tests biometric database, will consider making participation mandatory: http://bit.ly/5CZvCA #privacy
Re: last tweet, I take issue w/ the description of “promise” of personalized medicine as “no risk, no mess, no problem.” Complete straw man
Stumbling Towards Nirvana-The promises of personalized medicine have failed to materialize. That may be about to change http://bit.ly/628izq
WSJ on gene patents & the ACLU/Myriad litigation http://bit.ly/8XBYfj No new info, but a reminder that summary judgment args are tomorrow
RT @crossborderbio: Biotech Trends in 2010: Top Three Reasons Why Biotech Companies Should Use Social Media http://ow.ly/167SY5
The Financial Times offers an international perspective on the FDA and NIH: http://bit.ly/5Kletw (HT @nanopore)
Genes vs. environment and the role of genomic “dark matter” http://bit.ly/5TcsTl (HT @drjonboyg)
Connecting Invention to Entrepreneurship: Lessons from RTP and Other US Hotspots: http://bit.ly/557JBV
PWC report on DTC genetic testing: relatively small now, but “expected to grow rapidly in response to consumer demands and declining prices”
PWC Report Projects 11% Annual Growth in Personalized Medicine Market, to nearly $500BN by 2015: http://bit.ly/6F8qnK (via @gw_dailyscan)
Another Pathway Opens Up for DTC Consumers: http://bit.ly/6MlqkC
Kevin Davies of @bioitworld has a nice review of the @PathwayGenomics DTC offering http://bit.ly/83J1vD
Great piece from Atul Gawande on key to healthcare reform (controlling cost) & the way to achieve it (experiment) http://bit.ly/8KZNTg
New $250M North Carolina “Innovation Fund” is looking for a manager: http://bit.ly/4O3ojE
George Church shares his thoughts “In Support of Open Access for Genomic Research” http://bit.ly/7KDkuY
RT @PHGFoundation A field synopsis of pharmacogenetic studies http://bit.ly/7Sjrjm
Vandy, UT Dallas to Use NIH Grant to Pursue Genomic Data Integration, Privacy http://bit.ly/5bSMde (via @gw_dailyscan)
Supercharged Herceptin Nears Pivot Point, as ImmunoGen, Roche Await Data on Breast Cancer “Smart Bomb” http://bit.ly/4qaUto
Complete Genomics Aims for Positive Cash Flow by Mid-2010; Positions Itself for IPO http://bit.ly/57QSj5 (via @gw_dailyscan)
Interesting Xconomy article from @ldtimmerman on the new tech transfer boss/approach at Scripps: http://bit.ly/6wF1a0 (HT @ncbiotech)